Track Athenex's current cash ($32M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Athenex (ATNX) currently reports a current cash of $32M as of December 2022. That compares with $45M in the prior-year period — down 30.6% year over year. Use the charts on this page to explore Athenex's current cash history and peer comparisons.
Athenex's current cash decreased from $45M to $32M — a 30.6% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Athenex reported $32M in current cash as of December 2022. That compares with $45M in the prior-year period — down 30.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $32M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Athenex, and consider following ATNX for alerts when major investors trade the stock.
Athenex is classified in the Healthcare sector. On current cash, it currently shows $32M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATNX with unrelated industries.